[Mycotic vaginitis; therapeutic trials with sterosan during pregnancy].
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002750:Chlorquinaldol; D005260:Female; D006219:Halogens; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000627:therapeutic use*; D009181:Mycoses; D011247:Pregnancy; D011248:Pregnancy Complications; D014244:Trichomonas; D014245:Trichomonas Infections; D014247:Trichomonas Vaginitis; D014627:Vaginitis
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D006219:Halogens; D006846:Hydrocarbons, Halogenated; D002750:Chlorquinaldol
ANTISEPTICS, HALOGEN/therapeutic use; FUNGICIDES/therapeutic use; PREGNANCY/complications; VAGINITIS, TRICHOMONAS/in pregnancy
Vaginitis mycotica; behandlingsforsøog i graviditeten med sterosan.